NEW YORK — U.S. health officials on Wednesday recommended that people 50 and older get a shot against bacteria that can cause ...

Each year, the U.S. sees roughly 30,000 cases of invasive pneumococcal disease, which includes blood infections, brain and ...

The airline will appoint six new directors to its board, avoiding a proxy fight with the activist investor Elliott Investment ...

The CDC recommends that immunocompromised people age 65 and older should get a second dose of the 2024-2025 COVID vaccine.

All adults aged 50 and older should receive a vaccine against bacteria that can cause pneumonia and meningitis, federal ...

Semaglutide (Ozempic) was tied to a reduced risk of Alzheimer's disease diagnoses in people with type 2 diabetes, ...

In a 15-0 vote, ACIP recommended that MenB-4C be administered as a two-dose series at 0 and 6 months when given to healthy ...

Pfizer's Q3 consensus estimate is likely to be exceeded. Despite the underperformance over the past two months, see why PFE ...

There's some rumbling going on within Pfizer's investment community, as an activist hedge fund says that the company's ...

STAT's Readout LOUD podcast discusses Pfizer's woes, explains RFK Jr.'s 'MAHA' campaign, and mulls the latest about the Novo ...

J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $30.00. The ...